BCL6 and lymphoma: Interestingly, AID deficiency reduces the incidence of B lymphomas, but not pre-B lymphomas, whereas this deficiency also prevents GC- and post-GC-derived lymphomas, but not marginal zone lymphoma development, in Iμ Bcl6 transgenic mice (109).